I am a DECN old timer, but am a new comer to your board. I know nothing about this cabal, I assume it's for real, but I keep thinking. Who looses or looks foolish if they had to compete with Genviro ? Lets start with the large Cap companies with government sanctioned $ 100.00 plus lab tests by the millions. Then there are the new at home $ 119.00 tests from Lab Corp. & Quest. Lastly, If Genviro had a good showing. How does the FDA & CDC explain why they sat on it that long.
If nothing else it's delay, delay,delay. Don't kill the cash cow until it runs out. In the near future, the lab tests will only be used for symptomatic patients at doctor offices and hospitals. Healthy people may have concerns about going to certain venues. Ball games, Concerts, Night Clubs, whatever. Labs would be useless for this, but Genviro would be perfect. How much would they have to charge for 50000 tests in one day?
The big question is. Can it do the job? I'm in this stock until I get that answer.